johnsonoutdoors.jpg
Johnson Outdoors Announces Cash Dividend
September 25, 2024 06:00 ET | Johnson Outdoors Inc.
RACINE, Wisc., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced approval by its...
CHAMPION.jpg
ChampionX Publishes 2023 Sustainability Report
September 25, 2024 06:00 ET | ChampionX Corporation
ChampionX Corporation (Nasdaq: CHX) announces the release of its 2023 corporate sustainability report.
Alvotech hefur klíní
Alvotech hefur klíníska rannsókn á AVT16, fyrirhugaðri líftæknilyfjahliðstæðu við Entyvio
September 25, 2024 05:01 ET | Alvotech
Alvotech er einn tveggja aðila sem vitað er að hafi byrjað klíníska rannsókn á sjúklingum fyrir fyrirhugaða líftæknilyfjahliðstæðu við Entyvio (vedolizumab)Á síðustu tólf mánuðum, fram til loka...
Alvotech Initiates C
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024 05:01 ET | Alvotech
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...
Alvotech_logo.jpg
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024 05:00 ET | Alvotech
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...
Huize Holding Limited Reports Second Quarter 2024 Unaudited Financial Results
September 25, 2024 05:00 ET | Huize Holding Limited
SHENZHEN, China, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance...
Arcutis logo.png
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types
September 25, 2024 01:00 ET | Arcutis Biotherapeutics, Inc.
Arcutis today announced new pooled subgroup analysis results from the Phase 3 INTEGUMENT-1 and -2 trials.
Logo-DAB-1147x445-purple-2.png
PayMate מכריזה על כוונתה לרכוש את DigiAsia
September 24, 2024 22:24 ET | DigiAsia Corp
הערכת שווי DigiAsia ב-400 מיליון דולר מציגה את PayMate באינדונזיה עם הרחבה מיידית של נתח השוק, ומכוונת לרישום ציבורי ב-2025 מומבאי, הודו וניו יורק, Sept. 25, 2024 (GLOBE NEWSWIRE)...
verizon-logo.png
Verizon Business and SK Shieldus team up to bolster cybersecurity offerings
September 24, 2024 22:00 ET | Verizon Communications, Inc.
SEOUL, South Korea, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Verizon Business and SK Shieldus have agreed to collaborate to deliver cybersecurity solutions to South Korean and Asian enterprises operating...
Logo.png
Banzai Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 24, 2024 21:00 ET | Banzai International, Inc.
SEATTLE, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales...